ArticleFrontiers in genetics2026
Multiple primary and familial melanoma as distinct high-risk phenotypes: a retrospective cohort study.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Patients with multiple primary melanoma (MPM) and familial melanoma (FM) are commonly grouped as a single high-risk category, although they may represent biologically distinct entities reflecting different contributions of genetic susceptibility and environmental exposure. The aim of this study was to compare clinical, phenotypic, environmental, histopathological, and genetic features among patients with MPM only, FM only, and combined MPM+FM, as well as to identify independent predictors of MPM phenotype. Methods: In this retrospective observational study, 333 high-risk melanoma patients were stratified into MPM only, FM only, and MPM+FM. Clinical and histopathological variables were analyzed using appropriate statistical tests. Univariate and multivariate logistic regression models were used to identify independent predictors of MPM, comparing patients with MPM only versus those with FM only. Results: Age at first melanoma diagnosis differed significantly across groups (p < 0.001), with MPM patients presenting older age compared with FM and MPM+FM. Early-onset melanoma (<40 years) was more frequent in FM (40.7%) and MPM+FM (43.1%) than in MPM (21.0%; p = 0.001). A family history of melanoma-associated cancers was observed exclusively in FM and MPM+FM (p < 0.001). Tanning bed use was more frequent in patients with a familial component (p = 0.02). Histopathological features and nevus burden were comparable across groups. In both univariate and multivariate logistic regression analyses, increasing age (OR 1.04, 95% CI 1.02-1.07; p = 0.003) and male sex (OR 2.90, 95% CI 1.41-5.99; p = 0.004) were independently associated with MPM. Discussion: MPM and FM represent distinct high-risk melanoma phenotypes. MPM is associated with older age and male sex, suggesting a predominant role of cumulative environmental exposure, whereas FM is characterized by earlier onset and broader cancer susceptibility. These findings support phenotype-driven risk stratification and tailored surveillance strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.